Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease
- Substances:GolimumabGuselkumab
Slovakia- Participants:18–64 years · 65+ years
- Substances:Golimumab
Rare diseases
Investigational molecules
Locations
SlovakiaStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
SlovakiaStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
Slovakia
SlovakiaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
SlovakiaEfficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma
SlovakiaBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
SlovakiaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
SlovakiaComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
SlovakiaA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
SlovakiaA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
SlovakiaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
SlovakiaTell us about your condition – we search every trial in Europe and connect you with the right site.